Ault KA - Search Results

1

Human papillomavirus vaccines: an update for gynecologists.

Ault KA. Ault KA. Clin Obstet Gynecol. 2008 Sep;51(3):527-32. doi: 10.1097/GRF.0b013e31818092df. Clin Obstet Gynecol. 2008. PMID: 18677145 Review.

2

Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial.

Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, Alvarez FB, Bautista OM, Jansen KU, Barr E. Mao C, et al. Among authors: ault ka. Obstet Gynecol. 2006 Jan;107(1):18-27. doi: 10.1097/01.AOG.0000192397.41191.fb. Obstet Gynecol. 2006. PMID: 16394035 Clinical Trial.

3

Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trials.

Garland SM, Ault KA, Gall SA, Paavonen J, Sings HL, Ciprero KL, Saah A, Marino D, Ryan D, Radley D, Zhou H, Haupt RM, Garner EIO; Quadrivalent Human Papillomavirus Vaccine Phase III Investigators. Garland SM, et al. Among authors: ault ka. Obstet Gynecol. 2009 Dec;114(6):1179-1188. doi: 10.1097/AOG.0b013e3181c2ca21. Obstet Gynecol. 2009. PMID: 19935017

4

Epidemiology and natural history of human papillomavirus infections in the female genital tract.

Ault KA. Ault KA. Infect Dis Obstet Gynecol. 2006;2006 Suppl:40470. doi: 10.1155/IDOG/2006/40470. Infect Dis Obstet Gynecol. 2006. PMID: 16967912 Free PMC article. Review.

5

Human papillomavirus vaccination: current indications and future directions.

Gattoc L, Nair N, Ault K. Gattoc L, et al. Obstet Gynecol Clin North Am. 2013 Jun;40(2):177-97. doi: 10.1016/j.ogc.2013.03.007. Epub 2013 May 10. Obstet Gynecol Clin North Am. 2013. PMID: 23732024 Free PMC article.

6

Human papillomavirus infections: diagnosis, treatment, and hope for a vaccine.

Ault KA. Ault KA. Obstet Gynecol Clin North Am. 2003 Dec;30(4):809-17. doi: 10.1016/s0889-8545(03)00102-5. Obstet Gynecol Clin North Am. 2003. PMID: 14719852 Review.

7

Why is it appropriate to recommend human papillomavirus vaccination as cervical cancer prevention?

Bednarczyk RA, Figueroa-Downing D, Ault K. Bednarczyk RA, et al. Am J Obstet Gynecol. 2016 Apr;214(4):490-493. doi: 10.1016/j.ajog.2015.10.920. Epub 2015 Oct 31. Am J Obstet Gynecol. 2016. PMID: 26529369 Free PMC article. No abstract available.

8

Long-term efficacy of human papillomavirus vaccination.

Ault KA. Ault KA. Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S27-30. doi: 10.1016/j.ygyno.2007.07.078. Gynecol Oncol. 2007. PMID: 17938016 Review.

9

Human papillomavirus vaccines and the potential for cross-protection between related HPV types.

Ault KA. Ault KA. Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S31-3. doi: 10.1016/j.ygyno.2007.08.059. Gynecol Oncol. 2007. PMID: 18499916 Review.

10

Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.

Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FAR, Kinney WK, Massad LS, Mayeaux EJ, Saslow D, Schiffman M, Wentzensen N, Lawson HW, Einstein MH. Huh WK, et al. Among authors: ault ka. Obstet Gynecol. 2015 Feb;125(2):330-337. doi: 10.1097/AOG.0000000000000669. Obstet Gynecol. 2015. PMID: 25569009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters